Clinical trial Recruiting at 1 site Observational

Analyzing the genetic profiles of head and neck tumors

Official title: Molecular and Genomic Profiling of Head and Neck Tumors to Explore Biomarkers Associated With Prognosis and Response to Therapy

Run by Montefiore Medical Center · NCT00200486 · Data updated 2026-11-12

This study is trying to see if looking at the genes in head and neck tumors can help predict how well patients will respond to treatment and their overall outcomes.

More Head and Neck Neoplasms trials

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorMontefiore Medical Center
Academic / other
Drugs / interventionsimmunotherapy
Locations1 site (The Bronx, New York)
StatusRecruiting
StartedOctober 1, 2002
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedApril 9, 2026
Trial IDNCT00200486 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with actual or suspected malignant or non-malignant tumors of the head and neck who are undergoing biopsy or resection.

Probably not a fit

Patients with insufficient tissue available for both standard diagnostic evaluation and study specimen will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the genetic profiles of head and neck tumors and their correlation with treatment responses and patient outcomes. Utilizing genetic microarray analysis, the research identifies distinct gene expression patterns that may serve as better predictors of prognosis compared to traditional clinical variables. The study focuses on isolating specific genes that change expression during tumor progression and metastasis, providing insights into the malignant transformation process. By analyzing tumor samples, the study seeks to enhance understanding of how genetic factors influence cancer behavior and treatment efficacy.

Why it matters

Potential benefit: If successful, this study could lead to improved prognostic tools and personalized treatment strategies for patients with head and neck cancer.

How similar studies have gone: Previous studies using genetic profiling in similar contexts have shown promising results, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* actual or suspected malignant or non-malignant tumors of the head and neck
* planned biopsy and/or resection, or availability of paraffin embedded or stored frozen tumor tissue for non-genetic analysis

Exclusion Criteria:

* insufficient tissue available for both standard diagnostic evaluation and study specimen

Where it's running

  • Stelby Augustine
    The Bronx, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.